Equillium Stock (NASDAQ: EQ) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 40.000 / 360.709K |
Day Range | - - - |
52 Wk Range | 0.450 - 3.250 |
Market Cap | $71.348M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 1.4% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Equillium (NASDAQ: EQ) through any online brokerage.
Other companies in Equillium’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Kezar Life Sciences (NASDAQ:KZR), Intensity Therapeutics (NASDAQ:INTS), Burning Rock Biotech (NASDAQ:BNR) and Immuneering (NASDAQ:IMRX).
The latest price target for Equillium (NASDAQ: EQ) was reported by HC Wainwright & Co. on Tuesday, December 26, 2023. The analyst firm set a price target for 4.00 expecting EQ to rise to within 12 months (a possible 96.89% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Equillium (NASDAQ: EQ) is $2.0316 last updated March 27, 2024 at 5:26 PM EDT.
There are no upcoming dividends for Equillium.
Equillium’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Equillium.
Equillium is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.